Scarica l'app Stockscreener
20.18
1.20%
0.21
Precedente Chiudi:
$19.97
Aprire:
$19.9
Volume 24 ore:
427.10K
Relative Volume:
0.63
Capitalizzazione di mercato:
$1.04B
Reddito:
$412.82M
Utile/perdita netta:
$-8.19M
Rapporto P/E:
-130.95
EPS:
-0.1541
Flusso di cassa netto:
$64.17M
1 W Prestazione:
-6.22%
1M Prestazione:
-5.65%
6M Prestazione:
+28.24%
1 anno Prestazione:
+15.22%
Intervallo 1D:
$19.61
$20.84
Intervallo di 1 settimana:
$19.61
$22.06
Portata 52W:
$10.96
$23.24
Caredx Inc Stock (CDNA) Company Profile
Nome
Caredx Inc
Settore
Industria
Telefono
415-287-2300
Indirizzo
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, WAT, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
20.21 | 1.03B | 412.82M | -8.19M | 64.17M | -0.1541 |
TMO
Thermo Fisher Scientific Inc
|
439.68 | 162.90B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
163.88 | 114.60B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
545.84 | 41.71B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
332.13 | 32.32B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
112.04 | 31.57B | 7.07B | 1.29B | 993.00M | 4.5355 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-06 | Downgrade | Craig Hallum | Buy → Hold |
| 2025-08-26 | Iniziato | William Blair | Mkt Perform |
| 2025-01-15 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Underweight |
| 2024-08-19 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-05-13 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2023-11-09 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-03-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Downgrade | Craig Hallum | Buy → Hold |
| 2023-03-03 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2021-07-20 | Ripresa | BTIG Research | Buy |
| 2021-06-03 | Iniziato | Goldman | Buy |
| 2021-02-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-08 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-02 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-05 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-26 | Iniziato | BTIG Research | Buy |
| 2020-06-19 | Reiterato | H.C. Wainwright | Buy |
| 2019-10-01 | Ripresa | Craig Hallum | Buy |
| 2019-05-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Iniziato | Jefferies | Buy |
| 2018-10-23 | Ripresa | Raymond James | Strong Buy |
| 2018-09-18 | Reiterato | H.C. Wainwright | Neutral |
| 2017-11-27 | Iniziato | H.C. Wainwright | Buy |
| 2016-06-14 | Reiterato | Mizuho | Buy |
| 2015-09-29 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Iniziato | Craig Hallum | Buy |
| 2015-03-18 | Reiterato | Mizuho | Buy |
Mostra tutto
Caredx Inc Borsa (CDNA) Ultime notizie
ETFs Investing in CareDx, Inc. Stocks - TradingView
Rule 144 notice and recent sale by insider (CDNA) - Stock Titan
CareDx Lawsuit Resolution Refocuses Attention On Valuation And Growth Prospects - Sahm
[144] CareDx, Inc. SEC Filing - Stock Titan
CareDx expands HeartCare platform to transform post transplant care for heart recipients - Traders Union
How Investors Are Reacting To CareDx (CDNA) Profit Return, Higher 2026 Outlook And New Shelf Registration - Sahm
CareDx (CDNA) Successfully Resolves Legal Action - GuruFocus
CareDx(CDNA) Stock Options Chain | Quotes & News - Moomoo
CareDx Announces Dismissal of 2021 Qui Tam Suit - New Castle News
Earnings Preview: CareDx to Report Financial Results Post-market on April 28 - Moomoo
Technical Reactions to CDNA Trends in Macro Strategies - Stock Traders Daily
Insider Sell: Jeffrey Novack Sells 2,688 Shares of CareDx Inc (C - GuruFocus
CareDx (NASDAQ: CDNA) counsel's 2,688-share sale under 10b5-1 - Stock Titan
CareDx (CDNA) Q1 2026 Earnings Call Transcript - AOL.com
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The National Law Review
A Look At CareDx (CDNA) Valuation After Recent Share Price Momentum Cools - Yahoo Finance
CareDx (CDNA) General Counsel has 2,873 shares withheld to cover RSU taxes - Stock Titan
How Investors Are Reacting To CareDx (CDNA) Profitability Milestone And Higher 2026 Revenue Guidance - Sahm
CareDx (NASDAQ:CDNA) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
MSN Money - MSN
23 new CareDx hires receive 63,856 stock units under Nasdaq rule - Stock Titan
CareDx sharpens focus on core testing services - MSN
CareDx (CDNA) Q2 2025 Earnings Transcript - AOL.com
CareDx : 2025 Annual Report - marketscreener.com
CareDx : 2026 Proxy Statement - marketscreener.com
CDNA SEC FilingsCaredx 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Conflicted on These Healthcare Names: CareDx (CDNA), Biogen (BIIB) and Guardant Health (GH) - The Globe and Mail
H.C. Wainwright reiterates Neutral rating on CareDx stock By Investing.com - Investing.com Australia
H.C. Wainwright reiterates Neutral rating on CareDx stock - Investing.com
Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX), Stryker (SYK) and CareDx (CDNA) - The Globe and Mail
CareDx Acquires Navaris and Divests Lab Products to Accelerate Growth - HarianBasis.co
Analysts Offer Insights on Healthcare Companies: CareDx (CDNA) and Ultragenyx Pharmaceutical (RARE) - The Globe and Mail
CareDx Earnings Call: Growth Accelerates Amid Bold Pivot - TipRanks
CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing - The National Law Review
Q1 2026 Presentation (04/28/2026 00: 00 - marketscreener.com
CareDx (NASDAQ:CDNA) Trading Down 8.7%What's Next? - MarketBeat
CareDx sharpens precision medicine focus with $260m Naveris acquisition - Yahoo Finance
Caredx to acquire Naveris for up to $260 million - BioWorld News
CareDx : ESG Report (CareDx 2026 ESG Report) - marketscreener.com
CDNA Maintained by BTIG -- Price Target Raised to $28.00 - GuruFocus
CareDx to Acquire Oncology Diagnostics Company Naveris for $160 Million - Clinical Lab Products
CareDx, Inc Q1 2026 Earnings Call Summary - Yahoo Finance
CareDx (NASDAQ:CDNA) Price Target Raised to $28.00 at BTIG Research - MarketBeat
CareDx, Inc (NASDAQ:CDNA) Q1 2026 Earnings Call Transcript - Insider Monkey
BTIG raises CareDx stock price target on oncology diagnostics deal - Investing.com UK
BTIG raises CareDx stock price target on oncology diagnostics deal By Investing.com - Investing.com Nigeria
CareDx Inc (CDNA) Q1 2026 Earnings Call Highlights: Strong Reven - GuruFocus
CareDx Announces First Quarter 2026 Financial Results - BioSpace
CareDx Q1 2026 Earnings Call Transcript - MarketBeat
Caredx Inc Azioni (CDNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.19%
0.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):